Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Konftel Calls For Change As World Leaders Gather For Major Climate Summit

Konftel is urging the wider communications industry to follow its lead and take the greener route to success – after enabling customers to ‘conference with a clear climate conscience’.With the COP26 UN climate change conference now underway in Glasgow, Konftel has issued a rallying call having become the first manufacturer of its kind to achieve Climate Neutral certification. In an era of agile working with huge demand for conferencing and collaboration hardware, protecting the planet is just as important as connecting the world, says CMO Stefan Eriksson. “We were the first in the

Novedo has secured SEK 150 million pre-IPO private placement and contemplates issuance of a SEK denominated senior secured bond

In October 2021, Novedo Holding AB (publ) (“Novedo” or the “Company”) secured a SEK 150 million pre-IPO private placement where ABG Sundal Collier AB acted as financial advisor to the Company. To address the strong investor demand, the Company decided to increase the offering size of the pre-IPO private placement from SEK 100 million to SEK 150 million. The investment will be used to support future growth through actively acquiring companies with driven entrepreneurs, strong market positions and solid financial track record. Furthermore, Novedo has mandated ABG Sundal Collier AB and

Finnair complements Turku and Tampere flight connections with bus connections to lower the CO2 footprint of the route as of summer 2022

Finnair will resume flights to two of its domestic destinations, Turku and Tampere, where flight connections have been on hold since spring 2020 due to the pandemic. Finnair will complement the flight connections to Turku and Tampere with a new type of bus connection, to reduce the CO2 footprint of these routes. The routes are among the shortest in Finnair network, although they have been operated with energy-efficient ATR aircraft, their emissions load per passenger is clearly heavier than on other routes.   “Turku and Tampere are an important part of our network. Traveling on these

Invitation to Readly’s Q3 presentation on 11 November

Readly AB will publish its interim report for the third quarter 2021 on 11 November at 07:30 CET. The report will be presented in an audiocast and teleconference at 09.00 CET the same day.Maria Hedengren, CEO and Johan Adalberth, CFO, will present the report and answer questions. The presentation will be held in English.To listen to the conference by phone, please call:SE: +46850558368UK: +443333009030US: +18335268395Follow the presentation live on:Link to audiocast Report and presentation will be available for download

Executive Brief from CEO Michael Glantz: “Our new strategy yield results”

In October, it was 18 months since Michael Glantz became the CEO of myFC. In this Executive Brief, he shares his thoughts on the company's development and the news that has been communicated recently. His report exudes optimism and confirms that the change of strategy to B2B was the right decision.“In my first Executive Brief, I spoke about a number of challenges the company faced. I was then almost three months into my new position as CEO, after working for many years as CTO at the company. Today, just over a year later, a lot has happened. There are several interesting topics to reflect

Aker ASA: Information regarding dividend sent to shareholders due to an error

Due to an error, all shareholders have today received information regarding dividend payment of NOK 11.75 in November 2021. The dividend decision is on the agenda for consideration in today’s Board of Directors meeting in Aker ASA. The company will inform the market of any relevant decision when taken. -ENDS- For more information, please contact: Joachim Bjørni, Head of Investor Relations, Aker ASATel: +47 924 22 106E-mail: joachim.bjorni@akerasa.com Atle Kigen, Head of Media Relations and Public Affairs, Aker ASATel: +47 907 84 878Email: atle.kigen@akerasa.com This

Nomination Committee for Elicera Therapeutics appointed

Gothenburg, November 4, 2021 – Elicera Therapeutics AB (publ), a clinical stage cell and gene therapy company that develops immuno-oncological treatments focused on CAR T-cells and oncolytic viruses, announces that representatives of the largest owners have appointed the nomination committee ahead of the Annual General Meeting  2022.On April 26, the Annual General Meeting established rules to guide the work of the Nomination Committee. The three largest owners on September 30 2021, were Magnus Essand, Di Yu and Jamal El-Mosleh, who together control 47.1% of the votes, and will be the

Inhalation Sciences to present at Redeye Life Science Day November 11

(Stockholm, 4 November, 2021) Inhalation Sciences (ISAB) CEO Manoush Masarrat will present the latest developments for the company at Redeye Life Science Day on November 11. ISAB provide high-precision equipment and research services for aerosol and inhalation studies that can de-risk drug development projects.Redeye Life Science Day is a digital event where up to 50 companies will present their business and technologies, and take questions from  analysts and experts. The presentation is live broadcasted and can be followed at:  https://www.redeye.se/events/815899/redeye-life-science-day-

Terveystalo Plc: SHARE REPURCHASE 3.11.2021

Terveystalo Plc ANNOUNCEMENT  3.11.2021 Terveystalo Plc: SHARE REPURCHASE 3.11.2021 In the Helsinki Stock Exchange Trade date           3.11.2021Bourse trade         BuyShare                  TTALOAmount             17 000 SharesAverage price/ share    11,2598 EURTotal cost            191 416,60 EUR Terveystalo Plc now holds a total of 801 000 sharesincluding the shares repurchased on 3.11.2021 On behalf of Terveystalo Plc Nordea Bank Oyj Janne

Change to Date of Interim Report

Ayima today announces that it will change the date of the release of the Q3 Interim report, currently scheduled for November 26, 2021. The new date for the release will be November 8, 2021. The reason for the change is improved accounting and audit procedures have meant that the report will be completed signifantly earlier than previously expected. In light of these improved procedures, Ayima will also re-assess the scheduled dates for the release of subsequent reports and notify the market when the new dates have been decided.

INVISIO receives order for 40 Intercom systems from a European NATO country

INVISIO has received an order for 40 Intercom systems. The customer is a European NATO country. The order is the first somewhat substantial commercial follow-up order and thus significant for future marketing of the system. The order value is less than SEK 10 million. After an extensive evaluation process of the Intercom system the customer placed an order for another 40 or so systems. The customer intends to mount the systems in light transport vehicles, to enable effective internal communication while traveling. Interest in the Intercom system is great and since its launch several

BioStock: PolarCool’s presence in France gets local media boost

Between September and October, PolarCool signed two six-week evaluation agreements to introduce its brain cooling device PolarCap in France. Both agreements are with top-league ruby teams within the country. The local media sees the transactions as an important development for French Rugby, which has seen the amount of head injuries increase in recent years.Read the article at biostock.se : https://www.biostock.se/en/2021/11/polarcools-presence-in-france-gets-local-media-boost/ This is a press release from BioStock - Connecting Innovation & Capital. https:/

Q3 Report 2021 – invitation to conference call and audiocast

Stockholm, November 4, 2021 - On Tuesday, November 9, at 09.00 CET, IRRAS will host a conference call and an online presentation of its Q3 2021 interim report (which will have been published earlier on November 9 at 08.00 CET). The presentation will be held in English. The dial-in numbers for the conference call are:Sweden: +46 8 50 55 83 59Rest of the world: +44 33 33 00 92 71 The presentation will be webcast and can be accessed from the following web address: https://tv.streamfabriken.com/irras-q3-2021 Speakers: President and CEO Will Martin, Interim CFO Griffen Stapp, and

Invitation to presentation of Balco’s third quarter report 2021

Balco’s interim report for the third quarter 2021 will be published at 07:30 CET on November 18, 2021. A web-cast telephone conference will be held at 09:00 CET the same day, where CEO and President Kenneth Lundahl and CFO Michael Grindborn will present the results for the third quarter 2021.A possibility will be given to ask questions via the webcast and follow the presentation material live. The webcast, which afterwards also will be available on demand, will be accessible at Balco’s financial website, www.balcogroup.se or via the following link: https://tv.streamfabriken.com/balco-q3-

DBP International: Signed a collaboration partnership agreement with Alexavi for commercialization of Temodex®

Double Bond Pharmaceutical International AB (publ) (“DBP” or “Double Bond”) has entered into a collaborative partnership with Alexavi Ltd (“Alexavi”). This is a major step in Double Bond’s development process and marks the company’s commitment to move forward towards approval and commercialisation of Temodex® program, for the treatment of Glioblastoma. This collaboration will open up accessibility to a ground-breaking treatment paradigm in this therapeutic area.  Alexavi will be managing an Early Access to Treatment program on behalf of Double Bond to raise awareness of the treatment’s

NORDEN initiates share buy-back programme

ANNOUNCEMENT NO. 75 - 4 NOVEMBER 2021 The Board of Directors has decided to carry out a share buy-back of up to a total of USD 40 million (approximately DKK 263 million). The share buy-back programme is initiated pursuant to the authorisation granted to the Board of Directors, which entitles NORDEN to acquire treasury shares at a nominal value not exceeding 10% of the share capital at the market price applicable at the time of acquisition with a deviation of up to 10%. This authorisation was most recently renewed at NORDEN’s general meeting on 25 March 2021. PurposeThe purpose of

Nordea cancels repurchased shares

Nordea Bank AbpStock exchange release – Total number of voting rights and capital4 November 2021 at 9.15 EETNordea Bank Abp (“Nordea”) has today cancelled 42,602,988 treasury shares, which were held for capital optimisation purposes and acquired through share buy-backs, in line with the decision by the Board of Directors.The cancellation of the treasury shares has been registered with the Finnish Trade Register on 4 November 2021. After the cancellation, the total number of shares in Nordea is 4,007,348,931 and the total number of votes attached to the shares is 4,007,348,931.

NORDEN REPORTS BEST QUARTERLY RESULT IN 10 YEARS

ANNOUNCEMENT NO. 74 - 4 NOVEMBER 2021 For the third quarter of 2021, NORDEN reports a result of USD 65 million - the best quarterly in 10 years. This is driven by excellent Dry Operator results, capitalising on significant dry cargo rate increases and high market exposure by having secured T/C capacity early in the year at much lower costs. NORDEN has actively converted increases in the market value of its portfolio to profit through vessel sales, providing sales gains of USD 13 million in Q3. Expecting a very strong Q4 result driven by a strong position in Dry Operator, and

Assemblin Q3 2021 Interim Report

Increased profitability and strong order intake“Our strong focus on profitability and cash flow continues to yield results thanks to hard work with operational improvements. For the first time, we have now achieved an adjusted EBITA margin of 7 per cent on a rolling 12-month basis, which we are very proud of.”Mats Johansson, President and CEO, Assemblin Third quarter (the quarter) July–September 2021 · Net sales for the quarter increased by 5.9 per cent to SEK 2,296 million(2,168), of which a negative 4.4 percentage points were organic growth, 10.2were acquisition-driven and a

Atrium Ljungberg signs an agreement for a major acquisition in Slakthusområdet

Atrium Ljungberg signed an agreement to acquire the Palmfelt Center Kylhuset 28 leasehold in Slakthusområdet in Stockholm. This leasehold has a letting area of more than 30,500 m[2] and will be acquired at an underlying property value that will be based on an updated market valuation at the end of the year. This has been set preliminarily at SEK 1,560 million.Palmfelt Center was built at the end of the 1980s for Bankgirot. The building is home to approximately 26,000 m[2] of offices and 5,000 m[2] of data centres and warehouses. Current tenants include Försäkringskassan, Bostadsförmedlingen

Corning Joins the Cyclyx Consortium

PORTSMOUTH, New Hampshire, USA, November 3, 2021 – Cyclyx International, a consortium-based plastic feedstock management company with a mission to increase the recycling rate of plastic from 10% to 90%, has announced that Corning Incorporated, one of the world’s leading innovators in materials science, has joined as the newest member. With an initial focus on creating more circular pathways for plastics in the U.S. life sciences industry, Corning’s membership in the consortium will open up opportunities for increased landfill diversion by improving the recycling rate for its products used

New data on lecanemab to be presented at the 14[th] Clinical Trials on Alzheimer’s Disease (CTAD) conference

Stockholm, November 4, 2021 - BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) and partner Eisai today announced that they will hold several oral presentations revealing new data on lecanemab, at the 14th Clinical Trials on Alzheimer’s Disease (CTAD) conference, November 9-12, 2021, in Boston, Massachusetts and virtually. The presentations will provide deeper insights into lecanemab’s potential as a treatment for early Alzheimer’s disease.Eisai recently initiated a rolling submission of a Biologics License Application (BLA) for lecanemab, an investigational anti-amyloid beta (Aβ) protofibril

Report for the third quarter 2021

Financial and operating highlights 3Q21 (3Q20 in brackets): · Operating revenues were NOK 1 880 million (NOK 1 371 million) · EBITDA was NOK 279 million (NOK 144 million) · EBIT was NOK 14 million (NOK -306 million) · Net result after tax was NOK -157 million (NOK -398 million) Segment highlights 3Q21 (3Q20 in brackets): Renewable Energy · EBITDA NOK 174 mill. (NOK 131 mill.) · Higher and increasing power prices in 3Q · Low wind speeds in 3Q, 44% reduced like for like generation vs. 3Q20 · Högaliden project completed early October adding 19% expected

Autoliv and the Piaggio Group join forces to develop a scooter and motorcycle airbag

(Stockholm, Sweden and Pontedera, Italy, November 4, 2021) – Autoliv, Inc. (NYSE: ALV and SSE: ALIVsdb), the worldwide leader in automotive safety systems, and the Piaggio Group, one of the leading manufacturers of scooters and motorcycles, are collaborating to develop an airbag for powered two-wheelers, for greater rider safety.A joint development agreement was signed by the two parties for the purpose of developing airbags to provide greater protection for two-wheeler riders and enhance riding pleasure. The airbags will be mounted on the vehicle frame and will deploy in milliseconds.

There are no items matching the current filter
There are no more items matching the current filter
Back to top